News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,651 Results
Type
Article (8030)
Company Profile (142)
Press Release (478478)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52883)
Employer Resources (14)
FDA (9764)
Job Trends (8574)
News (238210)
Policy (17904)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (493)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (99)
Alliances (33157)
ALS (114)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (295)
Approvals (10436)
Artificial intelligence (345)
ASCO (160)
Autoimmune disease (228)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6959)
BIO (36)
Biologics (14)
BIOSECURE Act (1)
Biosimilars (119)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (3)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (522)
Cancer (3834)
Cardiovascular disease (231)
Career advice (245)
Career pathing (1)
CAR-T (182)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (497)
Cervical cancer (35)
Clinical research (48171)
Collaboration (1308)
Commercialization (6)
Compensation (1552)
Complete response letters (35)
COVID-19 (765)
CRISPR (65)
C-suite (821)
Cystic fibrosis (87)
Data (5998)
Denatured (4)
Depression (108)
Dermatology (80)
Diabetes (364)
Diagnostics (4230)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (162)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (171)
Earnings (73779)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88258)
Executive appointments (721)
FDA (12562)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (971)
Gene editing (127)
Generative AI (11)
Gene therapy (342)
GLP-1 (300)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9369)
Hematology (94)
HIV (55)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (70)
Immunology and inflammation (111)
Immuno-oncology (62)
Indications (169)
Infectious disease (960)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (266)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (47)
Layoffs (59)
Legal (5195)
Licensing (24)
Liver cancer (47)
Longevity (20)
Lung cancer (555)
Lung diease (8)
Lymphoma (261)
Machine learning (29)
Management (3)
Manufacturing (589)
Marketing (9)
MASH (118)
Medical affairs (2)
Medical device (8697)
Medtech (8860)
Mergers & acquisitions (14424)
Metabolic disorders (741)
mRNA (69)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1892)
NextGen: Class of 2026 (3151)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (169)
Pain (179)
Pancreatic cancer (213)
Parkinson's disease (211)
Partnered (12)
Patents (509)
Patient advocacy (1)
Patient recruitment (534)
Patient selection (14)
Peanut (33)
People (41419)
Peptides (5)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15553)
Phase 2 (21515)
Phase 3 (14520)
Pipeline (7951)
Policy (18)
Postmarket research (1570)
Preclinical (6566)
Press Release (34)
Prostate cancer (196)
Psychedelics (9)
Radiopharmaceuticals (198)
Rare diseases (602)
Real estate (3024)
Recruiting (6)
Regenerative medicine (7)
Regulatory (15058)
Reports (23)
Research institute (587)
Resumes & cover letters (45)
Rett syndrome (44)
RNA editing (8)
RSV (48)
Schizophrenia (104)
Series A (170)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (336)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (91)
Date
Last 7 days (350)
Last 30 days (1317)
Last 365 days (19029)
2026 (14265)
2025 (19241)
2024 (22992)
2023 (26538)
2022 (34591)
2021 (37169)
2020 (33468)
2019 (23240)
2018 (17470)
2017 (18744)
2016 (17917)
2015 (24247)
2014 (21679)
2013 (18127)
2012 (20202)
2011 (20440)
2010 (20317)
Location
Africa (229)
Alabama (80)
Alaska (2)
Arizona (313)
Arkansas (11)
Asia (17998)
Australia (2110)
California (12518)
Canada (3284)
China (556)
Colorado (509)
Connecticut (435)
Delaware (218)
Europe (24731)
Florida (1885)
Georgia (396)
Hawaii (3)
Idaho (46)
Illinois (740)
India (55)
Indiana (326)
Iowa (16)
Japan (437)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1245)
Massachusetts (8196)
Michigan (315)
Minnesota (578)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2747)
New Mexico (12)
New York (2938)
North Carolina (1325)
North Dakota (4)
Northern California (6300)
Ohio (298)
Oklahoma (14)
Oregon (16)
Pennsylvania (2329)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (78)
South Dakota (1)
Southern California (5221)
Tennessee (125)
Texas (2053)
United States (40579)
Utah (377)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (967)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
486,651 Results for "theratechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Theratechnologies in Talks with Anonymous Potential Buyer While Fielding Future Pak Buyout Offer
Future Pak—whose acquisition offer was rejected by Vanda Pharmaceuticals last summer—is offering to buy Theratechnologies for an unsolicited $255 million. The Canadian biotech is under an exclusivity agreement with another yet-to-be-disclosed potential purchaser.
April 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Theratechnologies Announces Completion of Acquisition by Future Pak
September 25, 2025
·
5 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Press Releases
Theratechnologies to Announce Second Quarter 2025 Financial Results
July 4, 2025
·
1 min read
Press Releases
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
September 15, 2025
·
5 min read
Press Releases
Theratechnologies Reports on its Annual Meeting of Shareholders
May 29, 2025
·
1 min read
Theratechnologies Announces Update on its Preclinical Oncology Research Program
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will phase down its preclinical oncology research activities.
March 22, 2024
·
6 min read
Press Releases
Theratechnologies Reports Financial Results for the Second Quarter 2025
July 10, 2025
·
20 min read
Business
Theratechnologies Appoints Elina Tea to its Board of Directors
Theratechnologies Inc. announced the appointment of Elina Tea, Chief Financial Officer at GLS North America, to its Board of Directors and as a member of the Company’s Audit Committee.
April 5, 2024
·
6 min read
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
Theratechnologies Inc. Today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET.
June 26, 2024
·
1 min read
1 of 48,666
Next
